U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
With a focus on specialty medicines, growth is driven by pharmaceutical needs for cost-effective, efficient production and ...
Gastrointestinal (GI) cancer is one of the major causes of cancer-related mortality worldwide. Colorectal, gastric, esophageal, liver and pancreatic cancer ...
Malaria remains a major global health burden, and the continued emergence of resistance to frontline therapies, including artemisinin-based combination ...
Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...
Near-infrared II (NIR-II) fluorophores possess transformative potential for biomedical applications. This review ...
Results of Phase 1 Dose-Escalation Cohort Including Antitumor Activity and Safety of REM-422 in Adenoid Cystic Carcinoma ...
Protein droplets serve important biological functions within cells, but in neurodegenerative diseases like Alzheimer's, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results